Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT04648449
Active, not recruiting Observational

Artificial Intelligence (AI) Support in Medical Emergency Calls

NCT04648449 · tracked via the Priya Life Science Norway tracker
Sponsor
Haukeland University Hospital
Phase
Observational
Started
2020-09-01
Last updated
2025-09-22

Condition(s) studied

Stroke, AcuteApoplexy; BrainEmergenciesCommunication, Multidisciplinary

Investigational drug(s) / intervention(s)

Artificial intelligence on emergency calls

Artificial intelligence on emergency calls: AI listens to all calls to Bergen EMCC, detecting calls regarding possible stroke.

Study summary

More than 12.000 patients suffer acute stroke in Norway every year, but less than half of them reach hospital within the current treatment window for thrombolysis. Stroke is the third-highest cause of death and the number one cause of severe disability requiring long time care at institutions. Consequently this has a high impact on society, patients and relatives, in addition to high costs related to care estimated to approximately 10 billion NOK per year. Although there are few studies on emergency medical communication centres (EMCC) in Norway, some have shown that the performance of the emergency medical communication centres can be improved. This project will seek to amend EMCC´s handling of acute stroke inquiries using artificial intelligence (AI), thus contributing to getting the patient to hospital in time for optimal treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All callers to medical emergency number 113 in Bergen Exclusion Criteria: * Age \<18

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Haukeland Universitetssykehus, Kirurgisk serviceklinikk, Nasjonalt kompetansesenter for helsetjenestens kommunikasjonsberedskap Bergen Bergen

More Haukeland University Hospital trials in Norway

Feasibility of a Digital Intervention for Patients Frequently Admitted to Psychiatric Acute Wards Starting soon
Weber B Ankle Fractures With Associated Posterior Malleolus Fracture Recruiting
Digital Treatment of Irritable Bowel Syndrome (IBS) Active, not recruiting
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study Active, not recruiting
Digital Intervention Targeting Cancer-related Cognitive Impairments Starting soon

Other trials for the same condition

The Akershus Study of Ischemic Stroke and Thrombolysis -1 Recruiting
The Immune Response to Stroke Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04648449 on ClinicalTrials.gov ↗ ← All trials in Norway